You just read:

Molecular Mechanisms That Could Explain Unique Adverse Events Observed in Patients Treated With the Antibiotic Telithromycin (Ketek™) is Reported in Antimicrobial Agents and Chemotherapy

News provided by

Cempra Pharmaceuticals

Dec 01, 2010, 07:00 EST